ROSLYN FORDE-TUCKER: Open Payments
NPI 1417620600 · WOLCOTT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 28 payments from 13 companies in 2025. Trend: 2023 $1,218 · 2024 $1,547 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $89 |
| ABBVIE INC. | 4 | $85 |
| SANOFI-AVENTIS U.S. LLC | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Abbott Laboratories | 2 | $47 |
| PFIZER INC. | 2 | $40 |
| Radius Health, Inc. | 1 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $30 |
Products named: TRELEGY ELLIPTA, QULIPTA, TZIELD, BREZTRI, FREESTYLE LIBRE 3, PREVNAR 20, AIRSUPRA, Tymlos.
Industry payments across CT — which companies pay providers there.
